These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin. Muff R, Dambacher MA, Perrenoud A, Simon C, Fischer JA. Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666 [Abstract] [Full Text] [Related]
4. In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin. Grauer A, Raue F, Schneider HG, Frank-Raue K, Ziegler R. J Bone Miner Res; 1990 Apr; 5(4):387-91. PubMed ID: 2343778 [Abstract] [Full Text] [Related]
9. One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray. Reginster JY, Jeugmans-Huynen AM, Albert A, Denis D, Franchimont P. J Bone Miner Res; 1988 Jun; 3(3):249-52. PubMed ID: 3213619 [Abstract] [Full Text] [Related]
11. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology]. Chapuy MC, Meunier P, Terrier M, David L, Vignon G. Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838 [Abstract] [Full Text] [Related]
12. Treatment of Paget's disease of bone with salmon calcitonin nasal spray. Gagel RF, Logan C, Mallette LE. J Am Geriatr Soc; 1988 Nov; 36(11):1010-4. PubMed ID: 3171038 [Abstract] [Full Text] [Related]
13. [Neutralizing antibodies against salmon calcitonin. The cause of a treatment failure in Paget's disease]. Grauer A, Frank-Raue K, Schroth J, Raue F, Ziegler R. Dtsch Med Wochenschr; 1994 Apr 08; 119(14):507-10. PubMed ID: 8156882 [Abstract] [Full Text] [Related]
14. Functional significance of antibody formation after long-term salmon calcitonin therapy. Hosking DJ, Denton LB, Cadge B, Martin TJ. Clin Endocrinol (Oxf); 1979 Mar 08; 10(3):243-52. PubMed ID: 572275 [Abstract] [Full Text] [Related]